Studying the mechanism of (-)Schisandrin B on the treatment of Parkinson's disease via ATG16L1/NLRP3 signaling pathway

Activity: Conference/talk/lecture/symposium/speech/workshop, etcEvent organized by non-HKBU units

Period26 Mar 202329 Mar 2023
Held atKeystone Symposia on Molecular and Cellular Biology, United States
Degree of RecognitionInternational